This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: June 22, 2023
Source: https://www.bloomberg.com/news/articles/2023-05-03/generic-drugmaker-lannett-files-for-chapter-11-bankruptcy
Reason: Filed for bankruptcy
Last recorded trade on: June 22, 2023
Source: https://www.bloomberg.com/news/articles/2023-05-03/generic-drugmaker-lannett-files-for-chapter-11-bankruptcy
Lannett Company
LCI
£0.51
Share price
0.00%
Change (1 day)
-71.10%
Change (1 year)
Categories
Earnings for Lannett Company (LCI)
Earnings in 2023 (TTM): -£0.17 Billion
According to Lannett Company's latest financial reports the company's current earnings are £0.31 Billion. In 2022 the company made an earning of -£0.11 Billion a decrease over its 2021 earnings that were of -£81.4 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Lannett Company from 2000 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -£0.17 Billion | 62.78% |
| 2022 | -£0.11 Billion | 23.09% |
| 2021 | -£81.4 Million | -51.41% |
| 2020 | -£0.17 Billion | -424.46% |
| 2019 | £51.62 M | -126.23% |
| 2018 | -£0.2 Billion | -255.9% |
| 2017 | £0.12 B | 170.58% |
| 2016 | £46.66 M | -66.69% |
| 2015 | £0.14 B | -4.54% |
| 2014 | £0.14 B | 619.53% |
| 2013 | £20.39 M | 80.15% |
| 2012 | £11.32 M | -908.06% |
| 2011 | -£1.41 Million | -118.48% |
| 2010 | £7.58 M | -17.12% |
| 2009 | £9.15 M | 453.37% |
| 2008 | £1.65 M | -119.89% |
| 2007 | -£8.32 Million | -239.11% |
| 2006 | £5.97 M | -115.19% |
| 2005 | -£39.35 Million | -532.64% |
| 2004 | £9.09 M | -47.76% |
| 2003 | £17.4 M | 41.23% |
| 2002 | £12.32 M | 165.35% |
| 2001 | £4.64 M | 5002.96% |
| 2000 | £0.09 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | £7.74 B | -5,314.59% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £20.52 B | -13,920.86% | 🇺🇸 USA |
 Abbott Laboratories ABT | £5.50 B | -3,808.86% | 🇺🇸 USA |
 Novartis NVS | £11.17 B | -7,622.60% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | £4.04 B | -2,826.46% | 🇬🇧 UK |